Associated Banc Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Associated Banc Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$61.35 - $90.47 $1,840 - $2,714	-30 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $996 - $1,538	30 New	30 $1,000
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $1,018 - $1,687	-39 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $801 - $2,461	39 New	39 $1,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

Stay updated on Associated Banc Corp with notifications on news.